TheraVasc

TheraVasc, Inc. is a privately held Cleveland, OH corporation which is developing repurposed drugs for new applications. Its first product targets patient populations with poor blood flow to the extremities, such as those suffering from peripheral artery disease (PAD). In the U.S., 16 – 19 million people suffer from PAD but no effective treatments are currently available.